SubHero Banner
Text

3rd Quarter 2016

Key topics in this quarter’s edition include:

  • Brodalumab for the treatment of plaque psoriasis
  • Ocrelizumab for the treatment of multiple sclerosis
  • Sarilumab for the treatment of rheumatoid arthritis

Download PDF

Text